Gene therapy developers are striving to platform their process development to more quickly and cost-effectively bring their drugs to market, meaning optimizing upstream process development has ...

Additionally, improving CAR-T biological efficiency could reduce dosing needs, further cutting costs and expanding access.

and efficacy of cell-based products Don't missed the opportunity to engage in a special panel discussion as industry experts discuss the present and future direction of the cell and gene therapy ...

That is, stopping the process just as important as starting it ... zebrafish rely on to repair damage to their hearts combined with viral vectors used for gene therapy in humans. In a new paper ...